New Jersey · 2026-2027 Regular Session · Bill
S 301: Classifies 7 Hydroxymitragynine as Schedule I drug.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 301 is a bill introduced in the New Jersey Senate on January 13, 2026. According to its official title, it concerns: Classifies 7 Hydroxymitragynine as Schedule I drug. Primary sponsor: Shirley Turner (Democratic), Kristin Corrado (Republican). It lists 2 additional sponsors. Most recent recorded action (March 16, 2026): Referred to Senate Budget and Appropriations Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Shirley Turner | Primary sponsor | Democratic | Senate | 15 |
| Kristin Corrado | Primary sponsor | Republican | Senate | 40 |
| Parker Space | Co-sponsor | Republican | Senate | 24 |
| Latham Tiver | Co-sponsor | Republican | Senate | 8 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to Senate Budget and Appropriations Committee
- Reported from Senate Committee, 2nd Reading
- Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee